Table 1.
IC50 values for neratinib and the methods of drug exposure in neratinib‐resistant cell lines
Cancer type | Cell line | Method of drug exposure |
Neratinib IC50 Mean ± standard error (μmol/L) |
---|---|---|---|
Breast | BT‐474 | — | 0.0028 ± 0.00019 |
BT‐474‐NRS | Stepwise | 0.97 ± 0.18 | |
BT‐474‐NRS2 | Stepwise | 1.45 ± 0.25 | |
BT‐474‐NRH | High | 1.69 ± 0.35 | |
BT‐474‐NRH2 | High | 1.44 ± 0.26 | |
Lung | H2170 | — | 0.029 ± 0.0059 |
H2170‐NRS | Stepwise | >10 | |
H2170‐NRH | High | 3.96 ± 0.49 |
‐, not applicable.